Cargando…

Peptidyl Arginine Deiminase Type 4 Gene Promoter Hypo-Methylation in Rheumatoid Arthritis

Protein citrullination is carried out by peptidylarginine deiminase type 4 (PAD4) enzyme. As a consequence of this process, post-translationally modified proteins are formed that become antigens for anti-citrullinated protein antibodies (ACPA). The study aimed at identifying whether the PADI4 gene i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kolarz, Bogdan, Ciesla, Marek, Dryglewska, Magdalena, Majdan, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408948/ https://www.ncbi.nlm.nih.gov/pubmed/32629762 http://dx.doi.org/10.3390/jcm9072049

Ejemplares similares

The value of anti-CarP and anti-PAD4 as markers of rheumatoid arthritis in ACPA/RF negative rheumatoid arthritis patients
por: Kolarz, Bogdan, et al.
Publicado: (2021)

Hypermethylation of the miR-155 gene in the whole blood and decreased plasma level of miR-155 in rheumatoid arthritis
por: Kolarz, Bogdan, et al.
Publicado: (2020)

Methylation Pattern of the SOCS3 and IL6R Promoters in Rheumatoid Arthritis
por: Cieśla, Marek, et al.
Publicado: (2020)

Antibodies against cyclic citrullinated peptide don’t decrease after 6 months of infliximab treatment in refractory rheumatoid arthritis
por: Kolarz, Bogdan, et al.
Publicado: (2010)

Association of anti-peptidyl arginine deiminase antibodies with radiographic severity of rheumatoid arthritis in African Americans
por: Navarro-Millán, Iris, et al.
Publicado: (2016)

Implications of Peptidyl Arginine Deiminase 4 gene transcription and polymorphisms in susceptibility to rheumatoid arthritis in an Iranian population
por: Bagheri-Hosseinabadi, Zahra, et al.
Publicado: (2023)

Galectin-9 Is a Possible Promoter of Immunopathology in Rheumatoid Arthritis by Activation of Peptidyl Arginine Deiminase 4 (PAD-4) in Granulocytes
por: Wiersma, Valerie R., et al.
Publicado: (2019)

Discovery of Novel Potential Reversible Peptidyl Arginine Deiminase Inhibitor
por: Aliko, Ardita, et al.
Publicado: (2019)

Release of Active Peptidyl Arginine Deiminases by Neutrophils Can Explain Production of Extracellular Citrullinated Autoantigens in Rheumatoid Arthritis Synovial Fluid
por: Spengler, Julia, et al.
Publicado: (2015)

Association of Cross-Reactive Antibodies Targeting Peptidyl-Arginine Deiminase 3 and 4 with Rheumatoid Arthritis-Associated Interstitial Lung Disease
por: Giles, Jon T., et al.
Publicado: (2014)

Rheumatoid arthritis antigens homocitrulline and citrulline are generated by local myeloperoxidase and peptidyl arginine deiminases 2, 3 and 4 in rheumatoid nodule and synovial tissue
por: Turunen, Sanna, et al.
Publicado: (2016)

Peptidyl Arginine Deiminase 2 (PADI2)-Mediated Arginine Citrullination Modulates Transcription in Cancer
por: Beato, Miguel, et al.
Publicado: (2020)

Antiphospholipid antibodies during 6-month treatment with infliximab: A preliminary report
por: Kolarz, Bogdan, et al.
Publicado: (2014)

Peptidyl arginine deiminase immunization induces anticitrullinated protein antibodies in mice with particular MHC types
por: Arnoux, Fanny, et al.
Publicado: (2017)

Implications of Porphyromonas gingivalis peptidyl arginine deiminase and gingipain R in human health and diseases
por: Chow, Yoke Chan, et al.
Publicado: (2022)

Expression of Peptidyl Arginine Deiminase 2 Is Closely Associated with Recurrence in Patients with Hepatocellular Carcinoma
por: Uhm, Sunho, et al.
Publicado: (2023)

FCER1G Gene Hypomethylation in Patients with Rheumatoid Arthritis
por: Podgórska, Dominika, et al.
Publicado: (2022)

Abrogation of collagen-induced arthritis by a peptidyl arginine deiminase inhibitor is associated with modulation of T cell-mediated immune responses
por: Kawalkowska, Joanna, et al.
Publicado: (2016)

A rapid ELISA based method to determine peptidyl-arginine deiminase activity in biological samples
por: Nijenhuis, S, et al.
Publicado: (2003)

Inhibition of peptidyl-arginine deiminases reverses protein-hypercitrullination and disease in mouse models of multiple sclerosis
por: Moscarello, Mario A., et al.
Publicado: (2013)

Neutrophils prevent rectal bleeding in ulcerative colitis by peptidyl-arginine deiminase-4-dependent immunothrombosis
por: Leppkes, Moritz, et al.
Publicado: (2022)

Porphyromonas gingivalis Peptidyl Arginine Deiminase (PPAD) in the Context of the Feed-Forward Loop of Inflammation in Periodontitis
por: Prucsi, Zsombor, et al.
Publicado: (2023)

The lack of association between PADI4_94 or PADI4_104 polymorphisms and RF, ACPA and anti-PAD4 in patients with rheumatoid arthritis
por: Ciesla, Marek, et al.
Publicado: (2022)

Murine Retinal Citrullination Declines With Age and is Mainly Dependent on Peptidyl Arginine Deiminase 4 (PAD4)
por: Hollingsworth, T. J., et al.
Publicado: (2018)

Inhibition of Peptidyl Arginine Deiminase-4 Prevents Renal Ischemia-Reperfusion-Induced Remote Lung Injury
por: Du, Mingjun, et al.
Publicado: (2020)

Applicability of Small-Molecule Inhibitors in the Study of Peptidyl Arginine Deiminase 2 (PAD2) and PAD4
por: Martín Monreal, María Teresa, et al.
Publicado: (2021)

PADI6: What we know about the elusive fifth member of the peptidyl arginine deiminase family
por: Williams, Jack P. C., et al.
Publicado: (2023)

Prevalence of selected organ-specific autoantibodies in rheumatoid arthritis and primary Sjögren's syndrome patients
por: Koszarny, Arkadiusz, et al.
Publicado: (2015)

A rigorous method for multigenic families' functional annotation: the peptidyl arginine deiminase (PADs) proteins family example
por: Balandraud, N, et al.
Publicado: (2005)

Peptidyl arginine deiminase type IV (PADI4) haplotypes interact with shared epitope regardless of anti-cyclic citrullinated peptide antibody or erosive joint status in rheumatoid arthritis: a case control study
por: Bang, So-Young, et al.
Publicado: (2010)

Response to ‘Peptidyl arginine deiminase type IV (PADI4) haplotypes interact with shared epitope regardless of anti-cyclic citrullinated peptide antibody or erosive joint status in rheumatoid arthritis: a case control study’
por: Ikari, Katsunori, et al.
Publicado: (2014)

Inhibition of Porphyromonas gingivalis peptidyl arginine deiminase, a virulence factor, by antioxidant-rich Cratoxylum cochinchinense: In vitro and in silico evaluation
por: Tan, Sheri-Ann, et al.
Publicado: (2022)

Anti-Protein-Arginine Deiminase 4 IgG and IgA Delineate Severe Rheumatoid Arthritis
por: Martinez-Prat, Laura, et al.
Publicado: (2022)

Systemic Inflammatory Parameters in Patients with Elderly-Onset Rheumatoid Arthritis (EORA) and Young-Onset Rheumatoid Arthritis (YORA)—An Observational Study
por: Targońska-Stępniak, Bożena, et al.
Publicado: (2021)

A complete phylogenetic analysis coupling expression data from EST databases. An example with a family of genes: the peptidyl arginine deiminase genes
por: Balandraud, N, et al.
Publicado: (2005)

Peptidyl arginine deiminase 2 (Padi2) is expressed in Sertoli cells in a specific manner and regulated by SOX9 during testicular development
por: Tsuji-Hosokawa, Atsumi, et al.
Publicado: (2018)

Identification of super-enhancer-driven peptidyl arginine deiminases as potential biomarkers and therapeutic targets for osimertinib-resistant non-small cell lung cancer
por: Li, Hang, et al.
Publicado: (2022)

Analysis of the peptidylarginine deiminase V gene in rheumatoid arthritis
por: Caponi, L, et al.
Publicado: (2003)

Inhibition of Peptidyl Arginine Deiminase 4-Dependent Neutrophil Extracellular Trap Formation Reduces Angiotensin II-Induced Abdominal Aortic Aneurysm Rupture in Mice
por: Wei, Ming, et al.
Publicado: (2021)

Changes in Tumor Necrosis Factor α (TNFα) and Peptidyl Arginine Deiminase 4 (PAD-4) Levels in Serum of General Treated Psoriatic Patients
por: Czerwińska, Joanna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s3r6ts3tbmkiahps7hj2kjrld1